Clinical trial

The HIt HArd and hiT Early in Multiple Sclerosis Trial

NCT07517185

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE2

Study timeline

Study start (actual)2026-09-01Date precision: day

Registry last updated2026-09-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-remitting Multiple Sclerosisunresolved

Interventions

Sequential treatment with rituximab and cladribineDRUG

Sponsors & collaborators

Uppsala Universitylead sponsor

Mapped research locations

UppsalaSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07517185 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.